Bright Minds Biosciences Inc.DRUGNASDAQ
Loading
P/E Ratio: Premium ValuationElevated
Percentile Rank33
Studio
Year-over-Year Change

Price-to-earnings ratio

Latest
-47.46
↑ 62% vs avg
Percentile
P33
Within normal range
Streak
2 yr
Consecutive declineElevated
Average
-124.27
Historical baseline
PeriodValueYoY Change
2025-47.46-1998.9%
2024-2.26-108.5%
2023-1.08+21.6%
2022-1.38+85.5%
2021-9.53+91.5%
2020-112.67+83.8%
2019-695.53-